US FDA to allow mixing and matching of Covid-19 boosters: NYT
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] The US Food and Drug Administration is planning to allow Americans to get a different booster shot of a Covid-19 vaccine than the one initially taken, the New York Times reported on Monday.
The FDA in September authorised a booster dose of Pfizer Inc and partner BioNTech's two-shot Covid-19 vaccine for those aged 65 and older and some high-risk Americans.
The regulator's advisory panel has also backed the use of Moderna Inc and Johnson & Johnson's Covid-19 vaccine booster shots.
The government would not recommend one shot over another, and it might note that using the same vaccine as a booster when possible is preferable, the NYT report said, citing people familiar with the agency's plans.
The FDA declined to comment on the matter.
US health officials have been under pressure to authorize the additional shots after the White House announced plans in August for a widespread booster campaign pending approvals from the FDA and the US Centres for Disease Control and Prevention.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
A study by the National Institutes of Health last week showed people who got Johnson & Johnson's Covid-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer and Moderna.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
